Table 4.
Morbidity, mortality and perioperative characteristics in prospective randomized trials comparing D1 to D2 Lymphadenectomy.
| First author, (reference) | Morbidity | Mortality | Op. Time (hrs) | mean LOS | Transfusion (units) | Transfused patients | ||||||
| D1 | D2 | D1 | D2 | D1 | D2 | D1 | D2 | D1 | D2 | - | - | |
| Dent (12) | 14% | 36% | 0% | 0% | 1,7 | 2,3* | 9,3 | 13,9* | 4 | 25* | - | - |
| Robertson (13) | 0% | 58% | 0% | 3% | 2,3 | 4,3* | 8 | 16* | 0 | 2* | 7 | 23* |
| Cuschieri (18) | 28% | 46%* | 5% | 11%* | 18 | 23* | - | - | - | - | ||
| Wu (20, 21) | 7% | 17%* | 0% | 0% | 3,6 | 4,5* | 15 | 19,6** | 1,3 | 2,1*† | - | - |
| Bonenkamp (14) | 25% | 43%* | 4% | 10%* | - | - | 18 | 25* | 113 | 170* | ||
| Degiuli (23) | 12% | 18% | 3% | 2% | 13 | 13 | ||||||
p < 0.05
blood loss
LOS, Length of hospital stay; Op. time, operative time.